Gyre Therapeutics Inc. (GYRE) Stock Analysis

Gyre Therapeutics Inc. (GYRE) is a publicly traded company in the HEALTHCARE sector. It trades at $5.56, carries a market capitalization of $563.74M. This page summarizes the public market data, fundamentals, and frequently asked questions for GYRE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.56
• Market Cap: $563.74M
• EPS: $-0.08
• 52-Week High: $9.42
• 52-Week Low: $5.67

Market Sentiment

Gyre Therapeutics Inc. currently has a Neutral sentiment score of 0.12.

About Gyre Therapeutics Inc.

None

GNG Research Analysis

GNG Research scores Gyre Therapeutics Inc. (GYRE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GYRE.

Frequently Asked Questions

Does GYRE pay dividends?

Gyre Therapeutics Inc. (GYRE) does not currently pay a regular dividend.

What is GYRE's market cap?

Gyre Therapeutics Inc. (GYRE) has a market capitalization of $563.74M with a current stock price of $5.56.